tb-500 vs bpc-157 dosage FDA Panel Recommends Compounding Unapproved Peptides Dr. Joel Gator Warsh |

Ask the Doctors is a syndicated column first published by UExpress syndicate.

"Despite the fact there's no evidence and real potential harm." Jiang did not respond to CBC's repeated requests for comment

Thats the real danger not BPC-157 itself, but whats in the vial

That published bioavailability finding does not say "every oral SLU-PP-332 product is inert." It says there is no published pharmacokinetic data supporting the assumption that oral capsules and tablets produce the effects seen in mouse studies

Patients with active malignancies, pregnancy, or significant hormonal imbalances should not use investigational peptides without specialist clearance